ArticleCurrent medical science2026
METTL3-m
Article in Current medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveWhile the RNA modification N
methodsA macrophage-specific METTL3-knockdown model was established. The functional effects of METTL3 deficiency were systematically evaluated using migration, invasion, phagocytosis, and polarization assays. Subsequent transcriptome sequencing (RNA-seq) and methylated RNA immunoprecipitation-quantitative PCR (MeRIP-qPCR) were employed to identify the key differentially expressed gene, lysyl oxidase-like 2 (LOXL2). This mechanistic link was ultimately confirmed through functional rescue experiments and reconstitution assays.
resultsMETTL3 deficiency significantly increased the migratory and invasive capacities of macrophages but attenuated their phagocytic activity, promoting a shift toward an M2-like polarization state. Mechanistically, METTL3 knockdown reduced m
conclusionThis study reveals a novel METTL3-m
Indexed as
Identifiers
42201485What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.